A new tool covering baseline retinal characteristics improves risk assessment for age-related macular degeneration, according to a report in the Archives of Ophthalmology. Previous risk models have ...

Age-related macular degeneration blinds more older adults in Western countries than any other retinal disease. Neovascular AMD, while less common than its dry counterpart, causes nearly all cases of ...

Is there a link between age-related macular degeneration and Alzheimer's disease? Age-related macular degeneration, or AMD, is a common eye condition and also a leading cause of vision loss among ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

Patients with diabetes using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may face more than twice the risk for developing neovascular age-related macular degeneration compared with those not ...

Use of acetylcholinesterase inhibitors (AChEIs) for dementia, such as donepezil (Aricept), may reduce the risk that patients will develop age-related macular degeneration (AMD), researchers said.

In patients with hypertension, angiotensin-converting enzyme inhibitors (ACEIs) did not reduce the risk of age-related macular degeneration (AMD) compared with calcium channel blockers (CCBs). Several ...

Share on Pinterest GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs are associated with a ...

Use of melatonin was associated with a decreased risk of development and progression of age-related macular degeneration (AMD), a retrospective cohort study suggested. Among propensity-matched ...